Azimilide: the first of a new type of class III antiarrhythmic agents New drugs and disease management 13 February 2013 Pages: 1 - 3
Accurate diagnosis and methodical treatment approach important in the management of OCD in children and adolescents New drugs and disease management 13 February 2013 Pages: 4 - 7
Opioids a viable option in some, but not all, patients with chronic non-cancer pain New drugs and disease management 13 February 2013 Pages: 7 - 9
Careful use of intravenous immunoglobulin therapy minimises adverse reactions Drug reactions and interactions 13 February 2013 Pages: 9 - 12
Health-related QOL measurements: key to optimal management of prostate cancer Drug economics and quality of life 13 February 2013 Pages: 13 - 16
